Jun 7, 2024, 11:30
Exploring IMDC Treatment Strategies at ESMO 2024 with Professor Manuela Schmidinger – MediaMedic
MediaMedic posted on LinkedIn:
“Exploring IMDC Treatment Strategies at ESMO 2023.
Oncology Frontier interviewed Professor Manuela Schmidinger at ESMO 2024 to discuss IMDC management for variable risk patients. Current studies show significant benefits of combined immunotherapy, especially for intermediate or poor-risk patients. Professor Schmidinger shared her insights on these treatment strategies and the latest advancements.
Stay tuned for the full interview!”
View the video attached to the post.
Source: MediaMedic/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 13:51
Nov 7, 2024, 13:12
Nov 7, 2024, 13:07
Nov 7, 2024, 12:50
Nov 7, 2024, 12:49
Nov 7, 2024, 12:27
Nov 7, 2024, 12:19
Nov 7, 2024, 12:17